These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4086916)

  • 21. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
    Reitan LJ; Closs O; Belehu A
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum lysozyme in leprosy.
    Naik SS; Gurnani S
    Lepr India; 1980 Oct; 52(4):501-7. PubMed ID: 7464056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dermal ultrastructure in leprosy.
    Van Hale HM; Turkel SB; Rea TH
    Arch Pathol Lab Med; 1984 May; 108(5):383-6. PubMed ID: 6546861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malaria, leprosy and dapsone.
    Saha K; Kapoor L; Arora VM; Chattopadhya D
    Southeast Asian J Trop Med Public Health; 2003 Sep; 34(3):501-4. PubMed ID: 15115119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deformities in leprosy patients of Indian armed forces treated/reviewed at Military Hospital Agra (a retrospective study).
    Tiwari VD; Mehta RP
    Lepr India; 1981 Jul; 53(3):369-78. PubMed ID: 7278142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A bacteriological and histopathological study of apparently normal skin in lepromatous leprosy.
    Katoch VM; Mukherjee A; Girdhar BK
    Lepr India; 1980 Oct; 52(4):508-12. PubMed ID: 7464057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study of 922 bacteriologically positive leprosy cases.
    Koticha KK; Nair PR; Juwatkar PS
    Int J Lepr Other Mycobact Dis; 1982 Sep; 50(3):330-4. PubMed ID: 6890538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapeutic trials in leprosy. 7. Trial of 50 mgm. DDS twice weekly in the treatment of lepromatous leprosy.
    Pearson JM; Pettit JH
    Int J Lepr Other Mycobact Dis; 1969; 37(1):40-5. PubMed ID: 4897238
    [No Abstract]   [Full Text] [Related]  

  • 29. [Relapses after multibacillary leprosy treatment].
    Rodríguez G; Pinto R; Laverde C; Sarmiento M; Riveros A; Valderrama J; Ordóñez N
    Biomedica; 2004 Jun; 24(2):133-9. PubMed ID: 15495593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of the administration of B663 [G 30 320, Lamprene, clofazimine (Geigy)] on three groups of lepromatous and borderline of leprosy.
    Rodriguez JN; Abalos RM; Reich CV; Tolentino JG
    Int J Lepr Other Mycobact Dis; 1974; 42(3):276-88. PubMed ID: 4617715
    [No Abstract]   [Full Text] [Related]  

  • 31. Twenty five years follow up of MB leprosy patients retreated with a modified MDT regimen after a full course of dapsone mono-therapy.
    Jing Z; Zhang R; Zhou D; Chen J
    Lepr Rev; 2009 Jun; 80(2):170-6. PubMed ID: 19743621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silent iritis in treated bacillary negative leprosy.
    Thompson K; Job CK
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):306-10. PubMed ID: 8862265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An evaluation of the immune state in leprosy.
    Mehra NK; Dasgupta A; Vaidya MC
    Lepr India; 1976 Jul; 48(3):231-7. PubMed ID: 15165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ocular complications in incident relapsed borderline lepromatous and lepromatous leprosy patients in south India.
    Daniel E; Koshy S; Joseph GA; Rao PS
    Indian J Ophthalmol; 2003 Jun; 51(2):155-9. PubMed ID: 12831146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug resistance in Nepali leprosy patients.
    Butlin CR; Neupane KD; Failbus SS; Morgan A; Britton WJ
    Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):136-41. PubMed ID: 8690972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of apoptosis in skin lesions of leprosy in relation to treatment and lepra reactions.
    Ajith C; Gupta S; Radotra BD; Arora SK; Kumar B; Dogra S; Kaur I
    Int J Lepr Other Mycobact Dis; 2005 Dec; 73(4):269-76. PubMed ID: 16830636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A single skin lesion--an unusual presentation of lepromatous leprosy.
    Yoder LJ; Jacobson RR; Job CK
    Int J Lepr Other Mycobact Dis; 1985 Dec; 53(4):554-8. PubMed ID: 4086919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Viability of Mycobacterium leprae in lepromatous patients after five years of dapsone monotherapy supplemented with two years of multidrug therapy.
    Sivaprasad N; Snehalatha S; Lobo D; Aschhoff M; Job CK
    Indian J Lepr; 1995; 67(4):427-33. PubMed ID: 8849919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prothionamide and dapsone therapy in leprosy--a clinical study.
    Kundu SK; Hazra SK; Chaudhury SK; Chatterjee B
    Indian J Lepr; 1985; 57(1):90-6. PubMed ID: 3839829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pattern of reactions in leprosy: a clinical appraisal.
    Sehgal VN; Rege VL; Mascarenhas MF
    Lepr India; 1977 Apr; 49(2):221-8. PubMed ID: 198609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.